Loading
Latest filing published 21 Jun 2021 for Verve Therapeutics, Inc., €16k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
One trade, one date: on 21 June 2021, Margaret Beaudoin disclosed an open-market purchase of €16k in Verve Therapeutics, Inc. No broader history exists yet. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration